Expand all sections

Nivolumab

Opdivo

Extended indication Extension of indication to include opdivo in combination with ipilimumab for the treatment of adults
Therapeutic value Possible added value
Registration phase Positive CHMP opinion

Product

Registration

Therapeutic value

Expected patient volume per year

Expected cost per patient per year

Potential total cost per year

Off label use

Indication extension

Other information